Vivos Therapeutics Inc VVOS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/20/24 EDT
2.24quote price arrow down-0.05 (-2.18%)
Volume
24,728
52 week range
1.96 - 48.79
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.24
  • 52 Week High48.79
  • 52 Week High Date11/29/23
  • 52 Week Low1.96
  • 52 Week Low Date05/13/24

Key Stats

  • Market Cap7.229M
  • Shares Out3.23M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta7.75
  • YTD % Change-81.99

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.24
  • 52 Week High48.79
  • 52 Week High Date11/29/23
  • 52 Week Low1.96
  • 52 Week Low Date05/13/24
  • Market Cap7.229M
  • Shares Out3.23M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta7.75
  • YTD % Change-81.99

RATIOS/PROFITABILITY

  • EPS (TTM)-11.00
  • P/E (TTM)-0.20
  • Fwd P/E (NTM)-0.64
  • EBITDA (TTM)-11.59M
  • ROE (TTM)-313.66%
  • Revenue (TTM)13.363M
  • Gross Margin (TTM)58.90%
  • Net Margin (TTM)-88.90%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vivos Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to...
R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Bradford Amman
Chief Financial Officer
Address
7921 Southpark Plaza,, Suite 210
Littleton, CO
80120
United States

Top Peers

SYMBOLLASTCHG%CHG
AXDX
Accelerate Diagnostics Inc
0.8774-0.0046-0.5215%
NEPH
Nephros Inc
2.29-0.07-2.97%
THMO
Thermogenesis Holdings Inc
0.6116+0.0247+4.2086%
RSLS
ReShape Lifesciences Inc
0.2109+0.0347+19.6657%
AVGR
Avinger Inc
3.05-0.53-14.80%